PDS Biotechnology's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; PDS Biotechnology is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is €-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -9.72M	$ -9.78M	$ -11.95M	$ -8.69M	$ -18.82M
EBITDA	$ -9.45M	$ -9.57M	$ -11.76M	$ -8.50M	$ -18.64M
Net Income Common Stockholders	$ -10.90M	$ -10.85M	$ -11.53M	$ -9.66M	$ -19.14M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 56.60M	$ 54.30M	$ 60.60M	$ 65.20M	$ 73.80M
Total Assets	$ 59.39M	$ 57.19M	$ 63.73M	$ 68.30M	$ 77.01M
Total Debt	$ 23.85M	$ 23.60M	$ 23.52M	$ 23.51M	$ 23.47M
Net Debt	$ -32.75M	$ -30.70M	$ -37.08M	$ -41.69M	$ -50.33M
Total Liabilities	$ 33.26M	$ 32.70M	$ 31.31M	$ 27.44M	$ 33.01M
Stockholders Equity	$ 26.13M	$ 24.48M	$ 32.44M	$ 41.01M	$ 44.00M
Cash Flow	-
Free Cash Flow	$ -8.46M	$ -7.18M	$ -4.81M	$ -13.19M	$ -7.53M
Operating Cash Flow	$ -8.46M	$ -7.18M	$ -4.81M	$ -13.19M	$ -7.53M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 10.77M	$ 802.33K	$ 196.26K	$ 4.58M	$ 9.71M

Currency in USD

PDS Biotechnology Earnings and Revenue History

Income Statement >

PDS Biotechnology Debt to Assets

Balance Sheet >

PDS Biotechnology Cash Flow

Cash Flow >

PDS Biotechnology Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing